McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access
McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access to the complete patient record. The goal behind the acquisition is to consolidate the technologies needed to automate and streamline workflow along every step of the diagnostic process from the time a test is ordered until the image is interpreted and the results are distributed to the referring physician, according to the company. The acquisition boosts McKesson's customer base to more than 500 installations. A.L.I. will be known as the McKesson Medical Imaging Group. Its employees will remain in the Vancouver, BC, location.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.